ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 153 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2017. The put-call ratio across all filers is 2.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $300,000 | -73.2% | 9,542 | -43.9% | 0.03% | +106.2% |
| Q4 2017 | $1,119,000 | -81.9% | 17,000 | -86.2% | 0.02% | -77.5% |
| Q3 2017 | $6,194,000 | +65.7% | 123,600 | +53.0% | 0.07% | +26.8% |
| Q2 2017 | $3,739,000 | -36.6% | 80,800 | -51.6% | 0.06% | -37.8% |
| Q1 2017 | $5,893,000 | +554.8% | 166,900 | +132.1% | 0.09% | +291.3% |
| Q4 2016 | $900,000 | +710.8% | 71,900 | +536.3% | 0.02% | +360.0% |
| Q2 2016 | $111,000 | -72.5% | 11,300 | -33.9% | 0.01% | -83.3% |
| Q3 2015 | $403,000 | -79.7% | 17,100 | -20.5% | 0.03% | -84.3% |
| Q1 2015 | $1,990,000 | – | 21,500 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |